December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

88.50 +3.24 (+3.80%)
Streaming Delayed Price Updated: 2:32 PM EDT, Sep 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From GeneDx
Via Business Wire
News headline image
Why NASDAQ:WGS qualifies as a high growth stock. ↗
Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQ:WGS). 
Via Chartmill
News headline image
GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners
From GeneDx
Via Business Wire
News headline image
GeneDx to Participate in Upcoming Investor Conference
From GeneDx
Via Business Wire
News headline image
The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts ↗
 
Via Benzinga
News headline image
GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA Analytics ↗
The company provides sequencing tools to help diagnose children with rare diseases. 
Via Investor's Business Daily
News headline image
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
From GeneDx
Via Business Wire
News headline image
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary
From GeneDx
Via Business Wire
News headline image
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year ↗
Via The Motley Fool
News headline image
Don’t Confuse Brains With A Bull Market, Or Price With Value ↗
If you are interested in the stock market, maybe it is time to stop focusing on The Fed. 
Via Talk Markets
News headline image
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields
From GeneDx
Via Business Wire
News headline image
GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
From GeneDx
Via Business Wire
News headline image
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? ↗
Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%). 
Via Benzinga
News headline image
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results ↗
 
Via Benzinga
News headline image
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance ↗
GeneDx stock rises as Q3 results beat expectations with EPS loss improvement, 44% revenue growth to $76.87M, and 77% increase in test revenue. 
Via Benzinga
News headline image
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights
From GeneDx
Via Business Wire
News headline image
Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening
From GeneDx
Via Business Wire
News headline image
GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns
From GeneDx
Via Business Wire
News headline image
GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
From GeneDx
Via Business Wire
News headline image
The Markets Are Ignoring Risk, But That Does Not Mean You Should... ↗
It is Fall clean-up time. Sell lagging and sagging companies. 
Via Talk Markets
News headline image
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx
Via Business Wire
News headline image
GeneDx to Participate in Fall Investor Conferences
From GeneDx
Via Business Wire
News headline image
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx
Via Business Wire
News headline image
WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q2 2024 ↗
WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients
From GeneDx
Via Business Wire
News headline image
GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights
From GeneDx
Via Business Wire
News headline image
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing ↗
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins. 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.